Ucla-CDU cfar - overall: project summary/abstract: this application is a resubmission for a new cfar that is a partnership between ucla and CDU

Active Project Grant Awarded Last action

Award ID
P30AI152501
Recipient
Awarding agency
Obligated
$11,996,147

Award facts

Assistance listing
93.397 Cancer Centers Support Grants
Completion date 92% complete
Funding
  • $11,028,827.00 Federal
  • $967,320.00 Non-federal
Funding agency
National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
Place of performance
Los Angeles, CA 90024, USA

Award details come from USAspending.gov.

Description

Our overarching goal is to create a nimble multi-institutional infrastructure that promotes equity and will connect and support investigators affiliated with both institutions to advance critical HIV science. The ucla-CDU cfar will strengthen and amplify the impact of existing research activities and launch new partnerships across LOS angeles and globally through our focus on three themes: we will stop HIV by preventing new HIV infections (PREVENTION), reducing morbidity among people living with HIV (TREATMENT) and developing strategies for eradication (art-free remission). This grant will fund aids-related activities and programs conducted by investigators at ucla, CDU and our affiliated institutions, which include harbor-ucla medical center in torrance; the ucla care clinic and the VA greater LOS angeles healthcare system in westwood; the ucla vine street clinic in west hollywood; and the drew cares, the CDU push coalition and the MLK OASIS clinic at CDU. These facilities are at ground zero for the aids epidemic in LOS angeles county, with the greatest number of persons living with HIV residing in the neighborhoods directly served by our hospitals and clinics. In addition to the facilities and programs based in LOS angeles, researchers at ucla and CDU have extensive partnerships with HIV programs around the globe that are aimed at building global capacity. The cfar will enhance our ability to deliver research at the interface of community by reaching communities most in need and by bringing to bear the talent of CDU and ucla researchers to address problems from a multi-disciplinary perspective while mentoring the next generation who better reflect the diversity of communities being served. The overall organization of the ucla-CDU cfar will allow US to efficiently and effectively manage aids research activities by harnessing the diverse expertise in our cfar, and by including linkages to community- based clinician investigators and communities. The action plan for the first year of requested support includes 6 cores and 1 scientific working group (SWG): the administrative core, developmental core, centralized laboratory support core, humanized mouse and gene therapy core, community engagement and clinical informatics core, clinical science core, and a translational research in substance use SWG. Relevance: research into the pathogenesis, TREATMENT and social aspects of HIV disease is required to end the epidemic. The ucla-CDU cfar seeks to catalyze and expand HIV research by providing the infrastructure to connect, support and enhance the capacity of investigators affiliated with ucla and CDU. This will be accomplished by stimulating the conduct and dissemination of high impact multidisciplinary research aimed at the NIH priorities of preventing new HIV infections (PREVENTION), reducing morbidity among people living with HIV (TREATMENT) and developing strategies for eradication (art-free remission).

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $147,825 $0
Amendment Ucla-CDU cfar - this application is a resubmission for a new cfar that is a partnership between ucla and CDU. Our overarching goal is to create a nimble… $56,700 $0
Amendment $151,916 $0
Amendment $51,700 $0
Amendment $527,698 $0
Amendment $527,698 $0
Amendment $188,574 $0
Amendment $188,574 $0
Amendment $188,574 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $51,700 $0
Amendment $147,825 $0
Amendment $2,057,141 $0
Amendment $267,000 $0
Amendment $755,595 $0
Amendment $755,595 $755,595
Amendment $755,595 $0
Amendment $755,595 $0
Amendment $755,595 $0
Amendment $56,700 $0
Amendment $63,900 $0
Amendment $63,900 $63,900
Amendment $63,900 $0
Amendment $56,700 $0
Amendment $63,900 $0
Amendment $51,700 $0
Amendment $147,825 $0
Amendment $200,000 $0
Amendment $85,500 $0
Amendment $1,261,777 $0
Amendment $63,900 $0
Amendment $267,000 $0
Amendment $51,700 $0
Amendment $147,825 $147,825
Original award $51,700 $0
Show all 39

Subawards

Subrecipient Amount Awarded
Charles R. Drew University Of Medicine And Science Dr. Locke will serve as a subaward lead, co-leading Aims 2 and 3 of the CHAMP CFAR SWG project. Her role will focus on fostering collaborative research,… $40,158
Partners In Hope Dr. Marguerite Thorp will serve as PI of the award. Mentor/co-investigator Dr. Sam Phiri, Programs Director at Partners in Hope, will supervise subrecipient… $41,094
Charles R. Drew University Of Medicine And Science Black/African American (or “Blackâ€�) and Latinx (BL) gay, bisexual, and other men who have sex and with men (MSM), transgender and gender non-binary… $124,326
Charles R. Drew University Of Medicine And Science Dr. D'Anna will receive support for start-up costs that will aid in establishing her research, education, and service activities within the department of… $75,600
University Of Alabama At Birmingham Dr. MacCarthy will assist the study by:1- Provide ethical approval from the Institutional Review Board (IRB) approval2- Support the engagement of community… $23,805
LOS Angeles Centers For Alcohol And Drug Abuse L.A. CADA is partnering with UCLA to evaluate and improve its downtown Los Angeles HIV testing and PrEP linkage program using Implementation Science. It has… $36,336
University Of Alabama At Birmingham Dr. MacCarthy will assist the study by:1- Provide ethical approval from the Institutional Review Board (IRB) approval2- Support the engagement of community… $48,101
The Rand Corporation This project will develop a status neutral Rise (an adherence counseling interven??on for Black Americans with HIV, through forma??ve work, community… $255,780
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Dr. Daar will serve on the Executive Committee for the UCLA-CDU CFAR. In this role he will provide representation and linkage with investigators at the… $105,851
Charles R. Drew University Of Medicine And Science The UCLA-CDU CFAR Community Engagement and Clinical Informatics Core (CECIC) aims to accelerate the impact of current HIV research for vulnerable populations… $2,423,130

Quick answers

Who received award P30AI152501?

P30AI152501 was awarded to University Of California, LOS Angeles by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 8, 2022.

How much is award P30AI152501 worth?

$11,996,147 has been obligated on P30AI152501: $11,028,827 in federal funding and $967,320 in non-federal funding.

Which agency awarded P30AI152501?

National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded P30AI152501, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award